Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05847192

Tau Networks in Psychotic Alzheimer's Disease

Sponsor: Northwell Health

View on ClinicalTrials.gov

Summary

This research project aims to understand the brain mechanisms behind the manifestation of psychotic symptoms in Alzheimer´s disease (AD), and nature of the unique relationship with tau pathology. Amongst the cognitive manifestations of psychosis are impairments related to frontal circuits (social cognition, working memory and executive function deficits). The investigator's previous work suggests a role of tau pathology (one of the hallmarks of AD neuropathology) in the manifestation of psychosis in AD. However, the cerebral mechanisms that underly this association remain poorly understood. The overarching aim of the study is is to investigate the mechanisms by which tau network pathology may promote the presentation of psychosis in AD.

Key Details

Gender

All

Age Range

65 Years - 85 Years

Study Type

OBSERVATIONAL

Enrollment

91

Start Date

2023-04-13

Completion Date

2029-12-31

Last Updated

2026-04-08

Healthy Volunteers

Yes

Interventions

DIAGNOSTIC_TEST

[18F]-PI2620 PET scan

The PET scan will measure the regional distribution of tau aggregation in AD patients with and without psychosis compared to Cognitively Unimpaired Healthy participants with the PET radiotracer \[18F\]-PI2620.

Locations (1)

The Feinstein Institutes for Medical Research

Manhasset, New York, United States